Strategy Paper of the NanoMedicine-Austria Technology Platform
Bibliographic record
Abstract
This document describes the strategic plans and position of the Austrian Technology Platform for Nanomedicine, NM-AT, and outlines its vision and mission, core topics, goals and activities. It serves as a strategic basis for the further development of the platform and explains how NM-AT is structured and how interested organizations and individuals can get involved and interact. Nanomedicine is the branch of medicine that uses the knowledge and tools of nanotechnology for the prevention, diagnosis and treatment of diseases. The use of nanoscale materials enables a better understanding of biological processes in the human body by focusing on the molecular and nanometric level and providing insights into tissue and cellular mechanisms that could not be studied by conventional means. Nanomedicine thus raises high expectations for better, more efficient and affordable healthcare for millions of patients and promises new solutions to improve medical treatment.Still, nanomedicine faces various challenges, such as nano-specific characterization, the controlled manufacturing of nanoproducts especially during upscaling, or regulatory challenges due to the lack of nano-specific standards. To overcome these challenges and fully exploit the great potential of nanomedical applications, multidisciplinary collaboration between different stakeholders is required. NM-AT brings together bio- and nanomedicine experts with the aim of increasing the visibility of nanomedicine as a benchmark for research and innovation, and promoting excellent basic and applied research to strengthen the transfer of nanomedical applications from the lab to clinical practice. It is an open platform that any interested organization or expert can join at any time, provided that the necessary expertise and interest in the platform is available.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.005 | 0.005 |
| Meta-epidemiology (narrow) | 0.001 | 0.001 |
| Meta-epidemiology (broad) | 0.001 | 0.001 |
| Bibliometrics | 0.002 | 0.001 |
| Science and technology studies | 0.002 | 0.001 |
| Scholarly communication | 0.009 | 0.006 |
| Open science | 0.002 | 0.004 |
| Research integrity | 0.006 | 0.004 |
| Insufficient payload (model declined to judge) | 0.109 | 0.076 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".